Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Armata Pharmaceuticals, Inc. | Chief Executive Officer, Director | Common Stock | 260K | $1.3M | $5.00 | Mar 14, 2024 | Direct |
Innoviva, Inc. | Director | Common Stock | 59K | $947K | $16.05 | May 22, 2023 | Direct |
Armata Pharmaceuticals, Inc. | Chief Executive Officer, Director | Stock Options (Right to Buy) | 240K | Mar 14, 2024 | Direct | ||
Innoviva, Inc. | Director | Non-statutory Stock Option | 20K | May 22, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARMP | Armata Pharmaceuticals, Inc. | Mar 14, 2024 | 2 | $0 | 4 | Mar 18, 2024 | Chief Executive Officer, Director |
ARMP | Armata Pharmaceuticals, Inc. | Dec 21, 2023 | 2 | $0 | 4 | Dec 26, 2023 | Chief Executive Officer, Director |
ARMP | Armata Pharmaceuticals, Inc. | Jul 10, 2023 | 0 | $0 | 3 | Jul 19, 2023 | Chief Executive Officer, Director |
INVA | Innoviva, Inc. | May 22, 2023 | 2 | $0 | 4 | May 24, 2023 | Director |
INVA | Innoviva, Inc. | Apr 25, 2022 | 2 | $0 | 4 | Apr 27, 2022 | Director |
INVA | Innoviva, Inc. | May 14, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |